<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Muchakayala SK</submitter><funding>Inyuvesi Yakwazulu-Natali</funding><funding>University of KwaZulu-Natal</funding><pubmed_abstract>We report an ideal method for quantifying impurities in mycophenolate mofetil drug substances and their oral suspension preparations. We developed a systematic and eco-friendly analytical approach utilizing quality by design (QbD) and green chemistry principles. Initially, the critical method parameters (CMPs) were screened using a D-optimal design. The robust final method conditions were optimized using a systematic central composite design (CCD). Through graphical and numerical optimization, the protocol conditions were augmented. The pH of mobile phase buffer (25 mM KH&lt;sub>2&lt;/sub>PO&lt;sub>4&lt;/sub>) (MP-A), initial gradient composition (% MP-A), flow rate (mL min&lt;sup>-1&lt;/sup>), and column oven temperatures (°C) are 4.05, 87, 0.4, and 30, respectively. The best possible separation between th</pubmed_abstract><journal>Scientific reports</journal><pagination>19138</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9646803</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>AQbD based green UPLC method to determine mycophenolate mofetil impurities and Identification of degradation products by QToF LCMS.</pubmed_title><pmcid>PMC9646803</pmcid><pubmed_authors>Saripella KK</pubmed_authors><pubmed_authors>Schaaf H</pubmed_authors><pubmed_authors>Marisetti VM</pubmed_authors><pubmed_authors>Muchakayala SK</pubmed_authors><pubmed_authors>Jonnalagadda SB</pubmed_authors><pubmed_authors>Katari NK</pubmed_authors><pubmed_authors>Kowtharapu LP</pubmed_authors></additional><is_claimable>false</is_claimable><name>AQbD based green UPLC method to determine mycophenolate mofetil impurities and Identification of degradation products by QToF LCMS.</name><description>We report an ideal method for quantifying impurities in mycophenolate mofetil drug substances and their oral suspension preparations. We developed a systematic and eco-friendly analytical approach utilizing quality by design (QbD) and green chemistry principles. Initially, the critical method parameters (CMPs) were screened using a D-optimal design. The robust final method conditions were optimized using a systematic central composite design (CCD). Through graphical and numerical optimization, the protocol conditions were augmented. The pH of mobile phase buffer (25 mM KH&lt;sub>2&lt;/sub>PO&lt;sub>4&lt;/sub>) (MP-A), initial gradient composition (% MP-A), flow rate (mL min&lt;sup>-1&lt;/sup>), and column oven temperatures (°C) are 4.05, 87, 0.4, and 30, respectively. The best possible separation between th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-19T10:37:15.153Z</modification><creation>2025-04-19T10:37:15.153Z</creation></dates><accession>S-EPMC9646803</accession><cross_references><pubmed>36352016</pubmed><doi>10.1038/s41598-022-22998-0</doi></cross_references></HashMap>